Detalhe da pesquisa
1.
Rationally designed chimeric PI3K-BET bromodomain inhibitors elicit curative responses in MYC-driven lymphoma.
Proc Natl Acad Sci U S A
; 120(36): e2306414120, 2023 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37643213
2.
New standards of care for treatment of diffuse large B-cell lymphoma.
Br J Haematol
; 204(4): 1132-1134, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38251726
3.
Infection risk and antimicrobial prophylaxis in bendamustine-treated patients with indolent non-Hodgkin lymphoma: An Australasian Lymphoma Alliance study.
Br J Haematol
; 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38485116
4.
Targeting Bfl-1 via acute CDK9 inhibition overcomes intrinsic BH3-mimetic resistance in lymphomas.
Blood
; 137(21): 2947-2957, 2021 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33259592
5.
Diagnosis and management of primary central nervous system lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance.
Intern Med J
; 52(9): 1624-1632, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34927329
6.
Excellent outcomes of transformed lymphomas in the rituximab era without autologous stem cell transplantation: an Australian single-centre experience.
Intern Med J
; 51(11): 1825-1834, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32609419
7.
Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B-cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma Alliance.
Br J Haematol
; 187(2): 174-184, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31236941
8.
Recommendation for TP53 mutation testing in newly diagnosed mantle cell lymphoma: a statement from working groups sponsored by the Victorian Comprehensive Cancer Centre.
Intern Med J
; 52(7): 1286-1287, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35879233
9.
Mosunetuzumab Safety Profile in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma: Clinical Management Experience From a Pivotal Phase I/II Trial.
Clin Lymphoma Myeloma Leuk
; 24(4): 240-253, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38195322
10.
Failure to achieve early disease response is associated with inferior survival in patients with newly diagnosed multiple myeloma.
Br J Haematol
; 182(5): 739-741, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28857117
11.
Molecular associations of response to the new-generation BTK inhibitor zanubrutinib in marginal zone lymphoma.
Blood Adv
; 7(14): 3531-3539, 2023 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36947202
12.
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma.
Blood Adv
; 7(17): 4926-4935, 2023 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37067952
13.
Cold agglutinin disease complicated by acrocyanosis and necrosis.
Ann Hematol
; 96(3): 509-510, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28050677
14.
Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study.
Blood Adv
; 6(4): 1232-1242, 2022 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34972202
15.
Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma.
Leukemia
; 36(6): 1654-1665, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35459873
16.
Infusional dose-adjusted epoch plus bortezomib for the treatment of plasmablastic lymphoma.
Ann Hematol
; 95(4): 667-8, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26801792
17.
Bispecific Antibodies: A Review of Development, Clinical Efficacy and Toxicity in B-Cell Lymphomas.
J Pers Med
; 11(5)2021 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33946635
18.
Excellent outcomes in older patients with primary CNS lymphoma treated with R-MPV/cytarabine without whole brain radiotherapy or autologous stem cell transplantation therapy.
Leuk Lymphoma
; 62(1): 112-117, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32981406
19.
Avelumab in Combination Regimens for Relapsed/Refractory DLBCL: Results from the Phase Ib JAVELIN DLBCL Study.
Target Oncol
; 16(6): 761-771, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34687398
20.
Serine Biosynthesis Is a Metabolic Vulnerability in FLT3-ITD-Driven Acute Myeloid Leukemia.
Cancer Discov
; 11(6): 1582-1599, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33436370